CPIG
RXRX icon

Chicago Partners Investment Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Chicago Partners Investment Group’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,272
Closed -$74.6K – 987
2024
Q4 		$74.6K Sell
10,272
-5,702
-36% -$38.3K ﹤0.01% 835
2024
Q3 		$101K Buy
+15,974
New +$115K ﹤0.01% 781

Other funds holding RXRX

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Chicago Partners Investment Group's RXRX Position: Q1 2025 in Review

Chicago Partners Investment Group sold out of Recursion Pharmaceuticals (RXRX) in Q1 2025, closing a stake of 10,272 shares — an estimated $74.6K sold.

Chicago Partners Investment Group first reported a position in RXRX in Q3 2024 and held it in 2 quarters. The position peaked at $101K in Q3 2024. 336 funds tracked by Wall St. Rank hold RXRX as of Q1 2025.

  • Chicago Partners Investment Group reported no remaining Recursion Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Chicago Partners Investment Group sold 10,272 Recursion Pharmaceuticals shares in Q1 2025, an estimated $74.6K.
  • Chicago Partners Investment Group first reported a position in Recursion Pharmaceuticals in Q3 2024 and held it in 2 quarters.
  • Chicago Partners Investment Group's Recursion Pharmaceuticals position peaked at $101K in Q3 2024.
  • 336 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2025.

Based on Chicago Partners Investment Group's 13F filing for Q1 2025, filed 9 May 2025.